Enterprise Value to EBITDA Multiple ratio Analysis of aTyr Pharma Inc - Deep Dive


Latest FY EV to EBITDA
Period Ending - Dec-23

0.502


Excellent EV to EBITDA
Period Ending - Dec-22
-1.07

Very Poor EV to EBITDA
Growth
146.87 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

-2.07


Very Poor EV to EBITDA
EV to EBITDA Analysis of aTyr Pharma Inc
Enterprise Value to EBITDA 0.502 of aTyr Pharma Inc indicate that a company is more attractive or undervalued in the market.
EV to EBITDA Ratio of LIFE rose handsomely by 146.87 % this year.
EV to EBITDA Ratio with value of 0.502 was highest in Year Dec-23 in last Five Years.
EV to EBITDA Ratio with value of -1.13 was lowest in Year Dec-21 in last Five Years.
Latest EV to EBITDA Ratio with value of 0.502 is Greater than Average EV to EBITDA of -0.433 in last five years.
Other EV to EBITDA Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
LIFE2.01.93 3.63 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple Formula
EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio
Tsr Value Index
Poor Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of aTyr Pharma Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
EV to EBITDA0.502-1.07-1.13-0.149-0.3140.1960.0231
Change146.87 %5.51 %-660.63 %52.60 %-260.27 %749.75 %-95.40 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of aTyr Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)